Qi Wang

机构：Dalian Institute of Chemical Physics, Second Affiliated Hospital of Zhejiang University · ORCID：0000-0002-2192-2923

发表论文 65 篇 · 总被引 1250 次 · h-index 19

代表论文

• Nanoparticle-enhanced proton beam immunoradiotherapy drives immune activation and durable tumor rejection (2023 · JCI Insight · 被引 36)
• GA receptor targeted chitosan oligosaccharide polymer nanoparticles improve non-alcoholic fatty liver disease by inhibiting ferroptosis (2024 · International Journal of Biological Macromolecules · 被引 12)
• Superior antitumor immune response achieved with proton over photon immunoradiotherapy is amplified by the nanoradioenhancer NBTXR3 (2024 · Journal of Nanobiotechnology · 被引 11)
• Tumor Microenvironment‐Responsive Polymer Delivery Platforms for Cancer Therapy (2025 · Angewandte Chemie · 被引 10)
• Distinct patterns of auto-reactive antibodies associated with organ-specific immune-related adverse events (2023 · Frontiers in Immunology · 被引 6)
• NPRL2 gene therapy induces effective antitumor immunity in KRAS/STK11 mutant anti-PD1 resistant metastatic non-small cell lung cancer (NSCLC) in a humanized mouse model (2025 · eLife · 被引 5)